Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
What this study shows
Hypoxia inhibits mTOR via REDD1-dependent activation of the TSC1/2 complex.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mammalian cells |
| Journal | Genes & development |
| Year | 2004 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.1256804 · PMID 15545625 · Free full text (PMC534650) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic (REDD1 / TSC1-TSC2) |
| Target | mTOR / REDD1 / TSC1-TSC2 |
| Model | Mammalian cells |
| Effect | Hypoxia inhibits mTOR via REDD1 acting through the TSC1/TSC2 tumor-suppressor complex |
In the Atlas
Related topics
Links in the pathway map
- Supports Hypoxia activates REDD1 (DDIT4)
- Supports REDD1 (DDIT4) activates TSC1/TSC2
More studies on this topic
- Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling (2008)
- ATF4 activates a transcriptional program that chronically suppresses mTOR activity and promotes neurodegeneration in Parkinson disease models (2026)
- Role of Autophagy in Scleral Remodeling During Form-Deprivation Myopia (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.